Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02675634 · ClinicalTrials.gov registry record · NA
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
A NA study, sponsored by Coloplast A/S.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT02675634: Completed NA study, sponsored by Coloplast A/S.
NCT02675634 is a NA study that has completed, run by Coloplast A/S. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02675634, a NA study, has completed, sponsored by Coloplast A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This clinical investigation is intended to explore the performance and safety of two newly developed ostomy products with regard to the products fit to body properties.
Primary Outcome
Subjects will evaluate the fit to body for each product by answering the question "how was the baseplates ability to fit the body contours in the area around the stoma?" The question is answered using an ordinal 5 point scale ranging from very poor to very good. The result shown below shows the fraction of subject who answered 'Good' or' Very Good' to the question.
Interventions
- DEVICE Coloplast Test A
- DEVICE Coloplast Test B
- DEVICE Subjects own product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02675634 record still lists
NCT02675634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Coloplast Test A is the first listed.
NCT02675634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02675634 about?
NCT02675634 is a clinical study titled "Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy". This clinical investigation is intended to explore the performance and safety of two newly developed ostomy products with regard to the products fit to body properties.
What is the current status of trial NCT02675634?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2016-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02675634?
The interventions under investigation include: Coloplast Test A (DEVICE), Coloplast Test B (DEVICE), Subjects own product (DEVICE).
Who is sponsoring clinical trial NCT02675634?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02675634's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia